Mathias Krockenberger

Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.

J. Becker, M. Buttmann, C. Beier, 2009, Cancer research.